Right in front of noses, page-24

let me just say that I garee with pretty much all the posts above, incl PD's info.

But these very questions were raised over 12mths ago, and I suspect at the last AGM?
and the points I raised in my post above, were those proffered by EDE as the reasons for not entering Aust.

Maybe times have changed? Maybe, given the slow uptake in Aust, maybe it is high time EDE now looked to Aust, and quickly?
EDE would surely now have a better understanding of the processes to go through in Aust, after their diligence in US?

I can state for a fact, that very experienced Aust executives, with significant experience in the concrtete industry (such experience in Aust, Asia and Europe) at my behest, approached EDE about supplying Edencrete in Aust, and were given little info. This person could not elicit the pertinent info he needed in order to take the matter further.

IMHO, there is now plenty of time-related info and stats from US trials to encourage interest in Aust.

I still think it is an issue of funding.

What intirgues me, is that EDE is Aust, the Board is Aust, the shares are only listed in Aust (don't count any off-boards in US), and the shareholders are in Aust, and the current potential investors are still in Aust -----> so, trials in Aust, with resultant publicity, photo opportunities, investor/broker/analyst field trips etc etc, would be an ideal platform for EDE to raise any further capital and interest.

So I guess it is probably up to aust s/h to shake the EDE tree, and try and get EDE board to look at a trial in Aust.

What better way to encourage Aust Option holders to exercise their Options, than an Aust trial?
Touch Edencrete, see it in action, feel it - cannot do that when it is on I-20 in Georgia.

Geez, if they specifically allocated money for a Aust trial, I would subscribe for some more shares to see it happen.

cheers